ACGME President and CEO Thomas J. Nasca Named Co-lead of NAM Opioid Collaborative Working Group

The National Academy of Medicine (NAM) announced that ACGME President and CEO Thomas J. Nasca, MD, MACP has been named co-lead of the NAM Action Collaborative on Countering the US Opioid Epidemic health professional education and training working group.

NAM designed four working groups to address key issues in formulating a comprehensive response to the opioid epidemic, which is a key issue for the US government. In addition to health professional education and training, working groups include prescribing guidelines and evidence standards; prevention, treatment, and recovery; and research, data, and metrics. In the coming months, each work group will announce goals, activities, and opportunities for collaboration.

Dr. Nasca will partner with representatives from federal, state, and local governments, health systems, associations and provider groups, health education and accrediting institutions, pharmacies, payers, industry, non-profits, and academia, to address the issue. To see the complete work group rosters, and for more information about the Action Collaborative, visit nam.edu/OpioidCollaborative.

The ACGME is also a part of NAM's Action Collaborative on Clinician Well-Being and Resilience, with Dr. Nasca serving as co-chair.